Cystic Fibrosis Trial, Recruiting NCT06642610 Sponsor: Indiana University Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT06642610
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with cystic fibrosis (CF) who are between 12 and 55 years old.
  • People with CF who do not have diabetes, or who have been found to have prediabetes (based on a specific sugar test called an OGTT and a blood test called HbA1c).
  • People who are willing to wear a small sensor (called a continuous glucose monitor, or CGM) and use a compatible smartphone to record their blood sugar levels.
  • People with CF who already have CF-related diabetes and are already using a CGM device — these individuals may be able to participate by sharing their existing CGM data, without needing to do the additional blood sugar tests.

Who may not be able to join:

  • People who are currently pregnant.
  • People who have had an organ or tissue transplant in the past.
  • People who are currently taking medications that suppress the immune system.
  • People who are currently taking steroid tablets by mouth, or any other medication known to affect blood sugar levels.
  • People who have an allergy to adhesives (sticky materials used on the skin).
  • People who have serious other health conditions that could affect blood sugar readings, such as a terminal illness or major organ failure.
  • People who have any condition that the trial doctor believes could make participation unsafe or affect the results of the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4344660570

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 June 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CGM Dynamic Index (CDI) for predicting prediabetes in people with cystic fibrosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov